from a T/A standpoint: 50% fib retracement completed (on low volume, very bullish) looking for a steady uptrend until FDA approval. <img src=http:////stockcharts.com/c-sc/sc?s=CTUM&p=D&yr=1&mn=0&dy=0&i=t41699384515&r=8748>